ABSTRACT-For characterization of the mechanism(s) of severe diarrhea due to the anticancer agent, irinotecan hydrochloride (CPT-11), examination was made of the relation of CPT 11 -related diarrhea to colonic prostaglandin E2 (PGE2) and water absorption in rats. Acute diarrheal symptoms were observed within 1 hr after the administration of CPT-11 to rats, with increased PGE2 and decreased water absorption in the colon. Treatment with atropine at 1 mg/kg, s.c. was noted to inhibit intestinal PGE2 and the CPT 11-related acute diarrheal symptoms, indicating that these diarrheal symptoms were mediated through the cholinergic nervous system accelerated functionally by CPT-11. On the other hand, daily treatment of CPT-11 at the same dose resulted in chronic diarrheal symptoms in all animals 3 days after CPT-11 treat ment. Histopathological changes observed in the descending colon and ileum of the rats included degener ation and necrosis of villi and cryptal cells and a decrease in the number of the goblet cells. Significantly increased PGE2 and impaired water absorption of the descending colon were also observed during the chronic diarrheal stage. It can be considered that the chronic diarrheal symptoms appear as a consequence of the gastrointestinal injury characterized by significant increase in PGE2 accompanied by impaired water absorption.
Irinotecan hydrochloride (CPT-11), a topoisomerase I inhibitor (1) (2) (3) , is useful for treating various tumors in cluding colonic cancer (4) and non-small-cell lung cancer (5) (6) (7) , which are refractory to many anticancer agents.
CPT-11 appears to be a very promising antitumor agent for chemotherapy, but severe diarrhea, in addition to myelosuppression, has rendered its conventional clinical application impracticable. In some patients, acute diar rhea occurs soon after CPT-11 administration followed by delayed diarrhea that is sometimes severe and thus a dose-limiting factor (4) (5) (6) (7) (8) .
It is well-established that prostaglandin E2 (PGE2) is responsible for the onset of diarrhea. Poor water absorp tion of the colon is considered to be one of the most im portant factors in the pathological basis of diarrhea (9) (10) (11) . The present study was conducted to clarify the mechanism(s) underlying the delayed diarrhea caused by CPT-11. A study was made to determine any possible relationship between CPT-11-related diarrhea and water absorption and PGE2 level in the gastrointestinal tract to find means to prevent the toxic effects of this anticancer agent.
MATERIALS AND METHODS

Animals
Male Wistar rats, 8-weeks-old and weighing 175 200 g (Japan SLC, Hamamatsu), were used in the present study. The animals were housed in an environment of 23±21C, 55-L10% humidity, 12-hr light-dark cycle (7:00-19:00) and free access to drinking water and ro dent chow (F-2; Funabashi Farm, Funabashi).
Reagents
CPT-11 was kindly provided by Yakult Honsha Co.
(Tokyo). It was first dissolved in distilled water by moderate heating at 601C, and then diluted with 9% NaCI to achieve the desired concentrations of CPT-11 in 0.9% NaCl. PGE2 was quantified using a RIA kit (NEN Research Products, Boston, MA, USA). Indomethacin and atropine sulfate were purchased from Sigma Chemi cal Co. (St. Louis, MO, USA). All other chemicals were of the highest grade commercially available.
Relationship of CPT-I1 dose levels to body weight, inci dence of diarrhea and colonic PGE2 in rats CPT-11 (30 or 60 mg/kg) was administered intra venously to rats once daily for 4 consecutive days, as reported by Takasuna et al. (12) . Body weight and onset of diarrhea were examined daily until the 5th day after CPT-11 treatment. Diarrhea that appeared within 1 hr of CPT-11 administration was regarded to be acute diar rheal symptoms, and diarrhea appearing after 6 24 hr was regarded as chronic diarrheal symptoms. Diarrhea was scored judging by the feces as normal (-), diarrhea (+) and watery diarrhea (+ +). The animals were sacrificed 24 hr after the last administration, and their colonic PGE2 was quantified according to the method of Kobayashi et al. (13) .
Relevance of CPT-11 treatment to the level of PGE2 in rat descending colon
The rats were treated intravenously with CPT-11 at 60 mg/kg. Each group contained 6 rats that were sacrificed for determination of PGE2 in the descending colon 1, 3, 6, 12 and 24 hr after CPT-11 treatment, respectively. To confirm any relation of acute diarrheal symptoms to PGE2 in the descending colon, the rats were assigned randomly to three groups and pretreated subcutaneously with atropine (1 mg/kg), indomethacin (5 mg/kg) or 0.9% NaCI 30 min before CPT-11 administration. All rats were sacrificed l hr after CPT-11 treatment and PGE2 in the descending colon was determined. In differ ent experiments, the rats were treated with CPT-11 once a day for 1 to 4 consecutive days. Rats were sacrificed 24 hr after the last dosing, and the ileum and descending colon was removed for PGE2 determination and histopatho logical study. Table 1 .
Incidence of acute diarrheal symptoms caused by CPT-11 in rats a)Diarrheal score was defined as follows: 0: no diarrhea , 1: diarrhea, 2: watery diarrhea. b)Number of rats for each score. CPT-11 was administered intravenously at doses of 30 or 60 mg/kg once daily for 4 consecutive days (Days 1-4). ** and ***: significantly different from the untreated group at P<0.01 and P<0.001, respectively (Mann Whitney U-test). a)Diarrheal score was defined as follows: 0: no diarrhea , 1: diarrhea, 2: watery diarrhea. b)Number of rats for each score. CPT-11 was ad ministered intravenously at doses of 30 or 60 mg/kg once daily for 4 consecutive days (Days 1-4). ** and ***: significantly different from the untreated group at P < 0.01 and P < 0.001, respectively (Mann-Whitney U-test).
Effects of CPT-11 on water absorption in the colon Rats were treated with CPT-11 once a day for 1 to 4 consecutive days. Colonic water absorption was deter mined 2 or 24 hr after CPT-11 injection on the first day and 24 hr on the second to forth days according to the method of Fedorak et al. (14) with minor modification. Briefly, a midline incision was made on the peritoneal wall of rats anesthetized with pentobarbital (50 mg/kg, i.p.), and the large intestine was exposed and tied to the cecum. The large intestine was cleaned by infusing 0.9% NaCI at 37C into the lumen, which was removed through the anus. A colonic loop was made by tying one end of the colon, about 0.5 cm from the cecum, to the other end, about 3 cm from the anus. The colonic loop was filled with 2 ml of 0.9% NaCl at 37 *C, which was removed for weighing 2 hr after 0.9% NaCI injection. Water absorp tion was expressed as the difference between the amount of solution injected and that retained in the lumen, by subtracting the wet weight of colonic tissue from that of the loop.
Statistical analyses
Mann-Whitney U-test was conducted in the rats with diarrhea. Other results were expressed as means±S.E. and analyzed by Fisher's least significant difference procedure (PLSD). P values less than 0.05 were consi dered to be statistically significant. 
RESULTS
Relationship of CPT-11 dose levels to body weight, inci dence of diarrhea and colonic PGE2 in rats CPT-11 at 60 mg/kg induced acute and chronic diar rheal symptoms from day 3 in all animals. At the same time, a marked decrease in body weight was also ob served. In the 30 mg/kg-treated group, diarrhea was ob served in some animals. Weight gain of this group was significantly suppressed, but no marked weight loss was noted (Tables 1 and 2, Fig. 1 ). Treatment with CPT-11 at 60 mg/kg significantly increased in the colonic PGE2 level on day 5, while in the 30 mg/kg-treated group, no marked change was noted in the colonic PGE2 level (Fig.  2) . Because diarrhea and the increase in colonic PGE2 were observed in all animals treated with CPT-11 at 60 mg/kg, this dose was used in the subsequent studies.
Relationship between PGE2 in the descending colon and the diarrhea caused by CPT-11 Acute diarrheal symptoms accompanied by significant increase in PGE2 in the descending colon was observed 1 hr following a single dose of CPT-11. The normal level was resumed at 3 hr and remained the same as that of the controls treated with 0.9% NaCI (Fig. 3) . No pathologi cal alteration could be detected in the colons of CPT-11 treated rats at this stage. Subcutaneous administration of atropine at 1 mg/kg inhibited CPT-11-caused acute diar rheal symptoms in all the animals with a normal PGE2 level. Treatment with indomethacin at 5 mg/kg sig nificantly lowered PGE2, but failed to prevent CPT-11 related acute diarrheal symptoms (Table 3) .
PGE2 in the descending colon increased with the fre quency of CPT-11 administration and become significant with three consecutive doses (Fig. 4) . Similarly, degener ation and necrosis of villi and cryptal cells and decrease in goblet cells in the descending colon as well as the ileum were more profound after three doses of CPT-11 (Table  4) . CPT was administered intravenously at 60 mg/kg. The rats were sacrificed 60 min after CPT injection. Each drug was given subcutaneously 30 min before CPT-l1 injection. * and ***: significantly different from the untreated group at P<0 .05 and P<0.001, respectively (one-way ANOVA followed by Fisher's PLSD test). Fig. 4 . Changes in colonic PGE2 after repeated doses of CPT-11 in rats. CPT-11 was administered intravenously at 60 mg/kg once daily. The rats were sacrificed 24 hr after CPT-11 injection each day. Each column represents the mean ±S.E. of 5-7 rats. * and **: significantly different from the untreated group at P<0.05 and P < 0.01, respectively.
Effects of CPT-11 on water absorption of the colon A single injection of CPT-11 decreased colonic water absorption in all rats within 2 hr after treatment, acute diarrhea symptoms were also observed. Water absorption in the colon became normal 24 hr after the last CPT-11 administration (Fig. 5A) . There was no marked decrease in colonic water absorption in rats treated with two doses of CPT-11. Chronic diarrheal symptoms were observed in all animals treated with three and four doses of with significantly decreased colonic water absorption (Fig. 5B) . Table 4 .
Histopathological data for intestinal mucosa of rats treated with CPT-11
CPT-11 was administered intravenously at 60 mg/kg once daily. The rats were sacrificed 24 hr after CPT-11 injection each day. Fig. 5 . Changes in colonic water absorption after CPT-l l injection in rats. A: CPT-11 was administered intravenously at 60 mg/kg. Colonic water absorption was measured 2 or 24 hr after CPT-11 injection. B: CPT-11 was administered intravenously at 60 mg/kg once daily. Colonic water absorption was measured 24 hr after CPT injection each day. Each column represents the mean ±S.E. of 4-7 rats. ** and ***: significantly different from each saline treated group at P<0.01 and P<0.001, respectively. El: saline, •: CPT-11.
DISCUSSION
CPT-11 exhibits its antitumor effects by inhibiting topoisomerase I. To elucidate the mechanism(s) of CPT 11-induced diarrhea, a major problem in the clinical application of this anticancer agent, the relationship of CPT-11 treatment to the intestinal PGE2 and water ab sorption was investigated. There have been two kinds of CPT-11-related diarrhea; acute diarrhea occurs soon following CPT-11 administration, and delayed diarrhea is sometimes severe and becomes a limiting factor for chemotherapy (4 8) .
In general, many factors such as stress, endotoxins of bacteria, cold exposure, food and drug intake, enteritis and ulcerative colitis lead to diarrhea (15-18). Increased PGE2 and poor water absorption of the colon would appear to be major etiologic factors (9) (10) (11) 17) . PGE2 has multiple functions in the gut, including improvement of gastrointestinal function and inhibition of water and electrolyte absorption (9, 14, (19) (20) (21) .
CPT-11 causes acute diarrhea by inhibiting cholinesterase (22). This can be clinically prevented by anticholinergic agents. In the present study, it was ob served that CPT-11-related acute diarrheal symptoms were accompanied by increase in PGE2 and impaired water absorption of the colon. Even though acute diar rheal symptoms as well as increased PGE2 were inhibited by atropine, indomethacin failed to inhibit CPT-11 induced acute diarrheal symptoms regardless of the decreased PGE2 level. We confirmed that a single dose of indomethacin at 5 mg/kg did not induce diarrhea or in testinal damage (23). Therefore, CPT-11-induced acute diarrheal symptoms would thus appear to be due to the cholinergic nervous system-mediated hyperperistalsis leading to increased PGE2 and impaired water absorption of the colon.
The in vivo metabolism and excretion of CPT-11 may possibly be related to chronic diarrheal symptoms. CPT 11 is metabolized in the liver by carboxylesterase to the active metabolite SN-38 (7-ethyl-l0-hydroxy campto thecin), which is further conjugated to glucuronic acid through catalysis by glucuronyltransferase.
The SN-38 glucronide thus formed is excreted into the intestine (24). Bacterial ,3-glucuronidase in the intestine may possibly release SN-38 from the conjugated complex, consequent ly impairing the gut so that chronic diarrheal symptoms come about and for which, there is no effective treatment (25). Chronic diarrheal symptoms caused by CPT-11 occurred on the 3rd day of the repeated treatment with CPT-11. At the same time, pathological change in the gastrointestinal tract was the most profound in this stage and accompanied by an increase in PGE2 and poor water absorption of the colon. PGE2 is also known to be in volved in the healing of gastrointestinal injury (9, 14, (19) (20) (21) . It is therefore reasonable to assume that the in crease in PGE2 during the stage of chronic diarrhea] symp toms was the result of the repair of gastrointestinal im pairment. However, such an increase may reduce colonic water absorption and thus aggravate diarrheal symptoms. For more effective clinical application of CPT-11, it is essential to prevent the intestinal damage caused by CPT 11. In a previous study, we showed that Hange-shashin to, a Kampo medicine, reduced the intestinal damage in rats treated with CPT-11. Therefore, Hange-shashin-to may prevent CPT 11 -related chronic diarrheal symptoms. In summary, CPT-11-induced diarrhea, especially chronic diarrheal symptoms, is shown by the present study to result from impairment of the gastrointestinal tract. This impairment causes significant increase in PGE2 with consequent reduction in colonic water absorp tion. Suppression of the intestinal damage caused by CPT-11 would inhibit the PGE2 and improve the func tions of the gut. This in turn would enhance the scope of CPT 11 application.
